Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Potential Treatments for Acute Lymphoblastic Leukemia through Integrated Genomic Network Analysis. | Pharmaceuticals (Basel) | 2022 | 36559013 | PubTator, text mining | PubMed |
| Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer. | J Pers Med | 2022 | 36556227 | PubTator, text mining | PubMed |
| Checkpoint Kinase 1 (CHK1) Functions as Both a Diagnostic Marker and a Regulator of Epithelial-to-Mesenchymal Transition (EMT) in Triple-Negative Breast Cancer. | Curr Issues Mol Biol | 2022 | 36547059 | PubTator, text mining | PubMed |
| Clinical characteristics, pathology features and outcomes of pediatric myeloid sarcoma: A retrospective case series. | Front Pediatr | 2022 | 36545668 | PubTator, text mining | PubMed |
| Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia. | BMC Cancer | 2022 | 36544113 | PubTator, text mining | PubMed |
| Leukemic stem cells and advances in hematopoietic stem cell transplantation for acute myeloid leukemia: a narrative review of clinical trials. | Stem Cell Investig | 2022 | 36540355 | PubTator, text mining | PubMed |
| Novel THPO variant in hereditary thrombocytopenia: A potential candidate variant for predisposition to myeloid neoplasm. | PLoS One | 2022 | 36534659 | PubTator, text mining | PubMed |
| NUC-7738 regulates β-catenin signalling resulting in reduced proliferation and self-renewal of AML cells. | PLoS One | 2022 | 36520954 | PubTator, text mining | PubMed |
| Zinc finger myeloid Nervy DEAF-1 type (ZMYND) domain containing proteins exert molecular interactions to implicate in carcinogenesis. | Discov Oncol | 2022 | 36520265 | PubTator, text mining | PubMed |
| Small noncoding RNAs play superior roles in maintaining hematopoietic stem cell homeostasis. | Blood Sci | 2022 | 36518603 | PubTator, text mining | PubMed |
| Heterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferation in mice via altered Runx1 splicing. | NAR Cancer | 2022 | 36518526 | PubTator, text mining | PubMed |
| Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studies. | Front Oncol | 2022 | 36505853 | PubTator, text mining | PubMed |
| Targeting Menin and CD47 to Address Unmet Needs in Acute Myeloid Leukemia. | Cancers (Basel) | 2022 | 36497385 | PubTator, text mining | PubMed |
| Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. | Cancers (Basel) | 2022 | 36497281 | PubTator, text mining | PubMed |
| Pre-Existing and Acquired Resistance to PARP Inhibitor-Induced Synthetic Lethality. | Cancers (Basel) | 2022 | 36497275 | PubTator, text mining | PubMed |
| [Molecular Genetic Characteristics of Acute Myeloid Leukemia Patients with CBFβ-MYH11 Positive]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 | 36476886 | PubTator, text mining | PubMed |
| Higher RUNX1 expression levels are associated with worse overall and leukaemia-free survival in myelodysplastic syndrome patients. | EJHaem | 2022 | 36467848 | PubTator, text mining | PubMed |
| Molecular characteristics and outcomes in Hispanic and non-Hispanic patients with acute myeloid leukemia. | EJHaem | 2022 | 36467830 | PubTator, text mining | PubMed |
| The RNA editing landscape in acute myeloid leukemia reveals associations with disease mutations and clinical outcome. | iScience | 2022 | 36465109 | PubTator, text mining | PubMed |
| DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer. | Proc Natl Acad Sci U S A | 2022 | 36459648 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=27